Biogen Inc (BIIB)
185.68
+0.90
(+0.49%)
USD |
NASDAQ |
Oct 04, 16:00
185.63
-0.05
(-0.03%)
After-Hours: 20:00
Biogen Shareholders Equity (Annual): 14.80B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 14.80B |
| December 31, 2022 | 13.40B |
| December 31, 2021 | 10.90B |
| December 31, 2020 | 10.70B |
| December 31, 2019 | 13.34B |
| December 31, 2018 | 13.04B |
| December 31, 2017 | 12.61B |
| December 31, 2016 | 12.14B |
| December 31, 2015 | 9.373B |
| December 31, 2014 | 10.81B |
| December 31, 2013 | 8.620B |
| December 31, 2012 | 6.962B |
| December 31, 2011 | 6.425B |
| December 31, 2010 | 5.397B |
| December 31, 2009 | 6.222B |
| December 31, 2008 | 5.806B |
| December 31, 2007 | 5.534B |
| December 31, 2006 | 7.150B |
| December 31, 2005 | 6.906B |
| December 31, 2004 | 6.826B |
| Date | Value |
|---|---|
| December 31, 2003 | 7.053B |
| December 31, 2002 | 1.110B |
| December 31, 2001 | 1.349B |
| December 31, 2000 | 1.106B |
| December 31, 1999 | 979.53M |
| December 31, 1998 | 718.61M |
| December 31, 1997 | 536.29M |
| December 31, 1996 | 484.37M |
| December 31, 1995 | 382.98M |
| December 31, 1994 | 329.93M |
| December 31, 1993 | 325.20M |
| December 31, 1992 | 285.00M |
| December 31, 1991 | 239.00M |
| December 31, 1990 | 145.70M |
| December 31, 1989 | 139.20M |
| December 31, 1988 | 68.00M |
| December 31, 1987 | 67.90M |
| December 31, 1986 | 89.30M |
| December 31, 1985 | 74.90M |
| December 31, 1984 | 91.90M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
10.70B
Minimum
2020
14.80B
Maximum
2023
12.63B
Average
13.34B
Median
2019
Shareholders Equity (Annual) Benchmarks
| Sage Therapeutics Inc | 799.53M |
| Ionis Pharmaceuticals Inc | 386.69M |
| Eli Lilly and Co | 10.77B |
| Regeneron Pharmaceuticals Inc | 25.97B |
| Moderna Inc | 13.85B |